GEF-Inhibitors: New small molecules for the treatment of autoimmune and malignant diseases
Scientists at the University of Bonn have identified new small molecules which can be used for the treatment of diseases characterized by alterations of proteins which are affected by Guanine nucleotide Exchange Factors (GEFs). Proteins targeted by GEFs are involved in integrin signalling, vesicle transport, or MAPK-signalling. These processes play an important role in the modulation of the immune response. Therefore, abnormal activation of the target proteins of GEFs can cause autoimmune and tumor diseases in humans.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 0
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Time to Leave Home? Revealed Insights into Brood Care of Cichlids
Shell-dwelling cichlids take intense care of their offspring, which they raise in abandoned snail shells. A team at the Max Planck Institute for Biological Intelligence used 3D-printed snail shells to…
Smart Fabrics: Innovative Comfortable Wearable Tech
Researchers have demonstrated new wearable technologies that both generate electricity from human movement and improve the comfort of the technology for the people wearing them. The work stems from an…
Going Steady—Study Reveals North Atlantic’s Gulf Stream Remains Robust
A study by the University of Bern and the Woods Hole Oceanographic Institution in the USA concludes that the ocean circulation in the North Atlantic, which includes the Gulf Stream,…